Estradiol Decline Before hCG Administration in COH Has a Negative Effect on IVF Outcomes in Patients Without OC Pretreatment
Yinci Zhu,Zhong Zheng,Bihong Fan,Yun Sun,Junyu Zhai,Yanzhi Du
DOI: https://doi.org/10.2147/ijwh.s423089
2024-03-07
International Journal of Women s Health
Abstract:Yinci Zhu, 1, 2 Zhong Zheng, 1, 2 Bihong Fan, 1, 2 Yun Sun, 1, 2 Junyu Zhai, 1, 2 Yanzhi Du 1, 2 1 Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200135, People's Republic of China; 2 Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, 200135, People's Republic of China Correspondence: Junyu Zhai; Yanzhi Du, Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200135, People's Republic of China, Tel +86-21-20284525; +86-21-20284518, Email ; Purpose: Together with ultrasound measurement of follicle size, serum estradiol (E 2 ) provides guidance for controlled ovarian hyperstimulation (COH). However, during the COH process, some patients experience decreased serum E 2 level, especially before human chorionic gonadotropin (hCG) trigger. In order to elucidate the effect of E 2 reduction as well as the role of oral contraceptive pretreatment, a retrospective study was performed in our center from 2013 to 2019. Patients and Methods: In total, 333 patients who experienced an E 2 decrease prior to hCG administration were recruited as E 2 decline group, while 333 patients with continuously E 2 increase during COH were considered as control group. Based on pretreatment strategy, the two groups were further categorized into oral contraceptive (OC) and non-OC sub-groups, and IVF and clinical outcomes were compared between paired groups. Results: Number of dominant follicles on hCG day and normally fertilized zygotes were significantly decreased in E 2 decline group, and the significantly reduced live birth rate in E 2 decline group indicated the close relationship between E 2 decline and clinical outcomes. To analyse further, we found that in patients without OC pretreatment, the pregnancy rate and live birth rate of E 2 decline group (n = 141) were significantly lower than control group (n = 136) (56.3% versus 68.0%, 50.8% versus 63.5%, respectively). However, for patients with OC pretreatment, no difference was detected between two groups, suggesting a potential effect of OC pretreatment on clinical outcomes. Conclusion: E 2 decline prior to hCG-triggering day adversely affects IVF and clinical outcomes in patients without OC pretreatment, especially fertilization rate and live birth rate. Keywords: estradiol decline, controlled ovarian hyperstimulation, oral contraceptive, in vitro fertilization, fertilization rate, live birth rate Serum estradiol (E 2 ) measurement is recognized as an indispensable parameter for follicle monitoring during controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF) cycles. 1,2 The E 2 value of different stages can be indicative for assessment and prognosis of treatment protocols when combined with other index. 3,4 Moreover, high level of serum E 2 associated with multiple follicle development in high responders may predict high risk for ovarian hyperstimulation syndrome (OHSS). 5,6 Prior to the prevalence of GnRH agonist protocols, decreased serum E 2 level before the day of human chorionic gonadotropin (hCG) administration was related to suboptimal IVF indexes even clinical outcomes. 7 Subsequently, several studies focused on the effects of serum E 2 decline in GnRH agonist protocols. A.K. Styer et al reported that decreased E 2 level before the day of hCG administration had no impact on pregnancy loss rate or live birth rate of the patients with GnRH-agonist protocol. 8 On the other side, S. Fisher et al concluded that in either standard long or flare protocol, spontaneously falling E 2 was linked to lower fertilization rate and clinical pregnancy rate compared to controls, whereas no such differences existed in patients with decreased E 2 due to deliberate protocol modification. 9 Thus, monitoring of E 2 level is closely related to drug adjustment during COH. In flare and antagonist protocols, oral contraceptive (OC) is frequently used as a pretreatment strategy before COH. Therefore, we focused on the role of E 2 drop before hCG-triggering and its relationship to OC pretreatment. Previous summary and conclusion were based mainly on two protocols and limited sample size, making the conclusion ambiguous. In order to clarify the above issues, we selected patients from a broader scale with different treatment protocols, -Abstract Truncated-
obstetrics & gynecology